Business Context and Reporting Period
Company: Stepan Company (Stepan Co.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2007
Business Overview: Stepan produces intermediate chemicals used in consumer and industrial applications. Operations are divided into three segments: Surfactants (73% of sales), Polymers (24% of sales), and Specialty Products (3% of sales). The company operates manufacturing sites in North America, Europe, and Latin America.
Key Financial Metrics
All figures in thousands, except per share data.
| Metric | Q3 2007 | Q3 2006 | YTD 9M 2007 | YTD 9M 2006 |
|---|---|---|---|---|
| Net Sales | $338,398 | $302,773 | $987,558 | $884,418 |
| Gross Profit | $34,868 | $35,896 | $107,951 | $101,474 |
| Operating Income | $8,203 | $11,277 | $29,254 | $24,415 |
| Net Income | $3,086 | $6,091 | $13,510 | $12,217 |
| Diluted EPS | $0.31 | $0.61 | $1.34 | $1.23 |
| Cash from Operations (9M) | $23,176 | $8,265 | ||
| Total Debt | $139,059 | $131,164 | ||
| Cash & Equivalents | $6,517 | $5,369 |
Material Changes vs. Prior Period
- Quarterly Performance: Net income declined 49% to $3.1 million in Q3 2007 compared to Q3 2006. This was driven by a $1.3 million pension curtailment charge, a $1.4 million increase in foreign exchange losses, and higher raw material costs impacting biodiesel and polyol margins.
- Year-to-Date Performance: Net income increased 11% to $13.5 million for the first nine months of 2007. This growth was supported by a $4.3 million gain on the sale of a product line, partially offset by a $3.5 million goodwill impairment charge.
- Revenue Growth: Consolidated net sales rose 12% in Q3 and 12% YTD, driven by a 6% increase in sales volume and a 6% increase in average selling prices (pass-through of raw material costs).
- Segment Highlights:
- Surfactants: Sales up 10% Q3/Q3, but operating income down 31% due to lower biodiesel profitability and the pension charge.
- Polymers: Sales up 17% Q3/Q3, but operating income down 9% due to production outages at the Phthalic Anhydride (PA) plant and higher raw material costs.
- Specialty Products: Sales and operating income both increased significantly due to volume growth in pharmaceutical and food ingredients.
Guidance, Outlook, and Risks
- Outlook: Management expects Q4 and full-year 2007 results to exceed prior year results. Surfactant volume and margin improvements are expected to offset projected declines in biodiesel profitability. The Polymer segment is expected to recover from PA production issues, driven by global polyol volume growth.
- Capital Expenditures: Projected full-year 2007 capital spending is $40.0 million to $42.0 million.
- Unusual Items:
- Product Line Sale: Sold specialty ester surfactant line to HallStar for $6.2 million cash plus asset transfer, resulting in a $4.3 million pretax gain (recorded Q2).
- Goodwill Impairment: Recorded a $3.5 million non-cash charge for the impairment of Stepan UK goodwill (recorded Q2) due to lower cash flow forecasts.
- Pension Curtailment: Recorded a $1.3 million loss in Q3 due to freezing the Millsdale/Anaheim defined benefit pension plan.
- Risks & Contingencies:
- Environmental/Legal: The company faces potential liabilities at 23 waste disposal sites. Estimated range of possible losses is $9.0 million to $38.0 million, with an accrued liability of $17.2 million as of Sept 30, 2007.
- Foreign Exchange: Significant losses ($1.2 million in Q3) due to the sharp decline in the U.S. dollar relative to foreign currencies, particularly affecting Canadian subsidiary receivables.
- Raw Materials: Continued escalation in raw material costs (e.g., soybean oil for biodiesel) pressures margins.
Investor Verification Checklist
- Margin Sustainability: Verify the ability to pass through rising raw material costs to customers without losing volume, particularly in the biodiesel and polyol markets.
- Production Reliability: Monitor the resolution of production outages at the Phthalic Anhydride (PA) plant and the associated costs of outsourcing production.
- Environmental Liabilities: Review the status of the Maywood, New Jersey site and other Superfund sites to ensure the $17.2 million accrual remains adequate against the $9M-$38M estimated range.
- Currency Exposure: Assess the impact of continued U.S. dollar weakness on future earnings, given the significant foreign exchange losses recorded in 2007.
- Pension Obligations: Confirm the long-term impact of the Millsdale pension plan freeze and the transition to defined contribution plans on future benefit costs.